Other News

Cardihab Cardiac Rehab App Spun Out Of CSIRO Ehealth Division

BRISBANE, Australia–(BUSINESS WIRE)–An Australian solution to dramatically improve recovery from a heart attack today became reality. Cardihab’s technology platform was developed by scientists at the Australian eHealth Research Centre (AEHRC), a joint venture between CSIRO and the Queensland Government. Cardihab was spun-out from CSIRO after raising venture capital investment of […]

MiCell Has significant raise for MiStent

Micell raises $62m for MiStent SES SEPTEMBER 19, 2017 BY BRAD PERRIELLO, Drug Delivery Business News Micell Technologies said last week that it raised a debt-and-equity round worth nearly $62 million from a syndicate of 51 unnamed investors. Paris-based Micell makes the MiStent SES sirolimus-eluting absorbable polymer coronary stent, designed to treat coronary artery […]

Meta-Analysis Shows RenalGuard(R) Offers Dramatic Benefit for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Cardiovascular Interventions

MILFORD, MA–(Marketwired – September 13, 2017) – A new meta-analysis suggests that the use of the RenalGuard System® reduces the rate of contrast-induced acute kidney injury (CI-AKI) compared to standard intravascular volume expansion in moderate-to-high-risk patients with chronic kidney disease who are undergoing cardiac interventional procedures. The study, published in the Journal […]

New Study Shows That Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality Associated with Transcatheter Aortic Valve Replacement (TAVR)

SANTA ROSA, Calif.–(BUSINESS WIRE)–Claret Medical® today announced publication of a new study in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions that underscores the role of the Sentinel Cerebral Protection System (CPS) in significantly reducing the early occurrence of stroke associated with transcatheter aortic valve replacement (TAVR). The study […]

2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction

The 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction, developed in collaboration with the ACC, AHA, APHRS, ASA, EHRA, IDSA, LAHRS, PACES, and STS, is intended to help clinicians in their decision-making process for managing leads and builds on the 2009 Transvenous Lead Extraction: Heart Rhythm Society Expert […]

Cardiovascular Systems Announces Anticipated Revenue Impact From Hurricanes Harvey And Irma

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) today said that the impact of Hurricanes Harvey and Irma on procedure volumes in the greater Houston area and throughout Florida will reduce fiscal 2018 first-quarter revenues. “Our thoughts go out to our employees in Florida and Texas and others affected by […]

BioVentrix Announces The 1st Revivent TC TransCatheter Ventricular Enhancement Procedure For Ischemic Cardiomyopathy Treatment At The University Heart Center Zurich In Switzerland

SAN RAMON, Calif., and ZURICH, Sept. 18, 2017 /PRNewswire/ — BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced the first clinical use of its closed-chest Revivent TC TransCatheter Ventricular Enhancement System at the University Hospital Zurich in Switzerland. A team led by Prof. Francesco Maisano, co-director […]

Cardiosolutions Key U.S. Patent Application For Adjustable “Spacer” Technology To Treat Heart Valve Regurgitation Receives Notice Of Allowance

WEST BRIDGEWATER, Mass., Sept. 18, 2017 /PRNewswire/ — Cardiosolutions, Inc., today announced that the United States Patent and Trademark Office has issued a Notice of Allowance to grant a key US patent covering the company’s proprietary ‘spacer’ technology for the treatment of regurgitation in incompetent heart valves. The allowed patent underlies the […]

SurModics (SRDX) Nabs Global Approvals of .014″ Low-Profile PTA Balloon Dilation Catheter

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced it has received U.S. Food and Drug Administration (FDA) 510(k) and CE Mark clearance for its .014” low-profile percutaneous transluminal angioplasty (PTA) balloon dilation catheter, designed for […]

LivaNova Defines Strategic Outlook at Investor Day

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, hosted its Investor Day today in New York to showcase the Company’s strategy, business goals and financial outlook. LivaNova’s Chief Executive Officer Damien McDonald shared his strategic vision for the Company, detailing plans for near- and long-term […]